Erez Israeli, Dr. Reddy's CEO
February 27, 2023 07:14 AM EST
Deals
Pharma

Dr. Red­dy's to buy Mayne Phar­ma’s US gener­ics drug list for at least $90M

Drew Armstrong

Executive Editor

Gener­ic drugs gi­ant Dr. Red­dy’s Lab­o­ra­to­ries has made a deal to ac­quire Mayne Phar­ma’s US gener­ics port­fo­lio for at least $90 mil­lion.

Mayne Phar­ma sells …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

A service from the Financial Times